News
When planning for your trip, keep possible nasal polyp triggers in mind, including changes in air pressure, exposure to allergens, and different climates or air quality. Pack plenty of nasal polyp ...
After nearly a decade of struggling to breathe — and losing her sense of taste and smell — award-winning chef Julia Sullivan ...
Nasal polyps can return even with treatment, but these strategies can help lower your risk.
Medical treatment for sinus infections typically includes antibiotics, antihistamines, nasal saline rinses, and decongestant sprays. In severe cases where these treatments fail, surgery may be ...
Chronic Rhinosinusitis With Nasal Polyps and Asthma: Understanding the Connection and Treatment Gaps
Chronic rhinosinusitis with nasal polyps increases the likelihood of developing coexisting conditions, such as asthma, underscoring the need for more effective, comprehensive treatments.
A survey of ENT clinicians reveals variability in managing chronic rhinosinusitis with nasal polyps, including steroid ...
Dupilumab in patients with diffuse type 2 CRSwNP had beneficial changes in nasal passage microbiota but did not alter gastrointestinal microbiota.
Hosted on MSN22d
7 Common Questions About Nasal Polyps, Answered - MSN
Nasal polyps are often associated with other health conditions, such as asthma. While effects of nasal polyps can be wide ranging and affect you long term, proper treatment can help you manage ...
A study published in July 2025 issue of Journal of Allergy and Clinical Immunology Global highlighted persistent challenges and fragmented care in managing individuals with severe asthma with an ...
Phase 2 POLARIS trial will evaluate the dosing, safety, and efficacy of WIN378 in patients with asthma, with a first data readout expected in mid-2026WIN378 has the potential to be the first-to-market ...
A person can address sinus infections with both home remedies, like nasal irrigation, and OTC pain relievers, as well as medical treatments such as antibiotics for bacterial infections or surgery ...
14d
Clinical Trials Arena on MSNFirst subject dosed in Upstream Bio’s Phase II trial of verekitug for COPD
Upstream Bio has dosed the first subject in the Phase II trial of verekitug in individuals with chronic obstructive pulmonary disease (COPD).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results